Clinical trial · Interventional
Low Level Laser Therapy for Hair Preservation With Chemotherapy for Breast Cancer
NCT01081106CI-TRIAL-00007639withdrawnN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to see whether low level laser therapy can help maintain normal hair growth on the scalp in people receiving chemotherapy, which is generally associated with hair loss.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Low-Level Laser Therapy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- Low-Level Laser Therapy
- interventionNames
- Procedure: Low-Level Laser Therapy
Primary outcomes (1)
- measure
- 10 Point Scale to evaluate hair loss
- timeFrame
- Photographs evaluated weekly during treatment, one month post chemotherapy
- description
- The primary objective is to evaluate the ability of Low-Level Laser Therapy (LLLT) to prevent chemotherapy induced alopecia in women receiving adjuvant chemotherapy for breast cancer.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Participants must have breast cancer and must be starting chemotherapy with Adriamycin or a taxane-based therapy. * Participants must be 18 years old or older * Participants must be female * Participant must agree to comply with therapeutic and follow-up schedule. * Patient must signed informed consent form. Exclusion Criteria: * Participants cannot have sensitivity to the laser light. * Participants cannot have used any topical or oral products to grow hair within 3 months of enrollment to this study. * Participants cannot be pregnant, lactating or planning on pregnancy during therapeutic schedule.
References
Publications (0)
Data not yet available
No reference posted for this study.